The decrease in cerebrospinal fluid (CSF) Aβ in OSA patients is also consistent with the pathological CSF pattern (low Aβ, high tau/p-tau) of AD and has been proven in a longitudinal study based on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database [25]. This evidence concerns the gene MAPT and Alzheimer disease.